XML 95 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure of detailed information about financial instruments [abstract]  
Summary of detailed information about financial instruments
The Company has designated ifs financial instruments as follows:
 
 December 31, 2023
  
Carrying
 value
    
Estimated
fair value
 
Financial Assets
     
Cash and cash equivalents
  
 
$   126,089
 
  
$
   126,089
 
Short-term investments
  
 
14,425
 
  
 
14,425
 
Derivative instruments in designated hedge accounting relationships
  
 
594
 
  
 
594
 
Loans and receivables:
     
Accounts receivable
    
525,854
      
525,854
 
Financial Liabilities
     
Derivative instruments in designated hedge accounting relationships
  
 
1,019
 
  
 
1,019
 
Other financial liabilities:
     
Accounts payable and accrued liabilities
  
 
561,120
 
  
 
561,120
 
Other current liabilities
  
 
7,936
 
  
 
7,936
 
Long-term debt – Revolving Credit Facility
  
 
314,705
 
  
 
314,705
 
Long-term debt – Term Loan
  
 
171,938
 
  
 
171,938
 
Long-term debt – Notes
  
 
826,625
 
  
 
823,198
 
Other long-term liabilities
  
 
18,070
 
  
 
18,070
 
               
 December 31, 2022
  
Carrying
 value
    
Estimated
fair value
 
Financial Assets
     
Cash and cash equivalents
   $    253,776      $    253,776  
Derivative instruments in designated hedge accounting relationships
     901        901  
Loans and receivables:
     
Accounts receivable
     455,841        455,841  
Preferred shares receivable
     27,954        28,702  
Financial Liabilities
     
Derivative instruments in designated hedge accounting relationships
     977        977  
Other financial liabilities:
     
Accounts payable and accrued liabilities
     628,086        628,086  
Long-term debt – Revolving Credit Facility
     459,202        459,202  
Long-term debt – Term Loan
     203,160        203,160  
Long-term debt – Notes
     846,500        869,288  
Other long-term liabilities
     21,757        21,757  
Summary of fair value measurement of financial assets and financial liabilities
      Carrying
 value
     Fair Value  
   Level 1      Level 2      Level 3  
Financial Assets
           
Short-term investments
   $    14,425      $    -      $    14,425      $    -  
Derivative financial instruments
     594        -        594        -  
Financial Liabilities
           
Derivative financial instruments
   $ 1,019      $ -      $ 1,019      $ -  
Long-term debt – Notes
     826,625        -        823,198        -  
Summary of detailed information about hedging instruments
The following table summarizes the Company’s commitments to buy and sell foreign currencies as at December 31, 2023:
 
           
Notional amount
  
Maturity
Canadian Dollar Denominated Contracts
Purchase contracts
   USD   
$      30,780
   January 2024 –December 2024
Sales contracts
   USD   
(21,321)
   January 2024 –November 2024
Summary of earnings before tax due to weakening of foreign currency
 Canadian dollar weakens by five percent
  
USD
    
AUD
    
BRL
 
Earnings from foreign operations
        
Earnings before income taxes
  
$
   5,920
 
  
$
    28
 
  
$
   (1,726)
 
Summary of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities The following table shows the Company’s sensitivity to a five percent weakening of the Canadian dollar against the U.S. dollar, Australian dollar, and Brazilian real. A five percent strengthening of the Canadian dollar would have an equal and opposite effect. This sensitivity analysis relates to the position as at December 31, 2023 and for the year then ended.
 
 Canadian dollar weakens by five percent
  
USD
    
AUD
    
BRL
 
Financial instruments held in foreign operations
        
Other comprehensive income
  
$
   12,446
 
  
$
   639
 
  
$
   246
 
Financial instruments held in Canadian operations
        
Earnings before income taxes
  
$
(10,042)
 
  
$
-
 
  
$
-
 
Summary of maturity analysis for derivative and non derivative financial liabilities
A liquidity analysis of the Company’s financial instruments has been completed on a maturity basis. The following table outlines the cash flows, including interest associated with the maturity of the Company’s financial liabilities, as at December 31, 2023:
 
($ thousands)
  
Less than 3
months
 
  
3 months to
1 year
 
  
Greater
than 1 year
 
  
Total
 
Derivative financial instruments
           
Foreign currency forward contracts
   $     596      $     423      $     -      $     1,019  
Accounts payable and accrued liabilities
     561,120        -        -        561,120  
Other current liabilities
     7,936        -        -        7,936  
Long-term debt – Revolving Credit Facility
     -        -        314,705        314,705  
Long-term debt – Term Loan
     13,226        39,678        119,034        171,938  
Long-term debt – Notes
     -        -        826,625        826,625  
Other long-term liabilities
     -        -        18,070        18,070  
Summary of maturity analysis for financial assets held for managing liquidity risk
($ thousands)
  
December 31, 2023
 
Cash and cash equivalents
  
$
   126,089
 
Short-term investments
  
 
14,425
 
Total Revolving Credit Facility (US$700,000)
  
 
925,820
 
Less:
  
Drawings on the Revolving Credit Facility
  
 
314,705
 
Letters of Credit
1
  
 
137,982
 
Available for future drawings
  
$
613,647
 
1
This represents the letters of credit that the Company has funded with the Revolving Credit Facility. Additional letters of credit of $48 million (US$36 million) are funded from the US$70 million LC Facility. Refer to Note 20 “Long-Term Debt” for more information.